MFG
MDGL icon

Magnus Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Magnus Financial Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,820
Closed -$1.54M – 309
2020
Q4 		$1.54M Hold
13,820
– – 0.15% 55
2020
Q3 		$1.64M Hold
13,820
– – 0.19% 45
2020
Q2 		$1.56M Sell
13,820
-3,593
-21% -$353K 0.17% 48
2020
Q1 		$1.16M Hold
17,413
– – 0.16% 65
2019
Q4 		$1.59M Hold
17,413
– – 0.23% 52
2019
Q3 		$1.5M Hold
17,413
– – 0.28% 46
2019
Q2 		$1.82M Hold
17,413
– – 0.35% 36
2019
Q1 		$2.18M Buy
+17,413
New +$2.16M 0.44% 29

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnus Financial Group's MDGL Position: Q1 2021 in Review

Magnus Financial Group sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2021, closing a stake of 13,820 shares — an estimated $1.54M sold.

Magnus Financial Group first reported a position in MDGL in Q1 2019 and held it in 8 quarters. The position peaked at $2.18M in Q1 2019. 137 funds tracked by Wall St. Rank hold MDGL as of Q1 2021.

  • Magnus Financial Group reported no remaining Madrigal Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Magnus Financial Group sold 13,820 Madrigal Pharmaceuticals shares in Q1 2021, an estimated $1.54M.
  • Magnus Financial Group first reported a position in Madrigal Pharmaceuticals in Q1 2019 and held it in 8 quarters.
  • Magnus Financial Group's Madrigal Pharmaceuticals position peaked at $2.18M in Q1 2019.
  • 137 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2021.

Based on Magnus Financial Group's 13F filing for Q1 2021, filed 5 May 2021.